Invasive aspergillosis in liver transplant recipients, an infectious complication with low incidence but significant mortality

Table 2 Clinical and laboratory information of patients with invasive aspergillus infection¹

Covariate	Number (percent)
Diagnosis (proven)	9 (40.9%)
Diagnosis (probable)	13 (59.1%)
Site of diagnosis (isolated pulmonary)	19 (86.4%)
Site of diagnosis (isolated sinusitis)	2 (9.1%)
Site of diagnosis (peritonitis)	1 (4.5%)
Positive galactomannan (serum)	5 (22.7%)
Positive galactomannan (BAL)	8 (36.4%)
Positive galactomannan (N/A)	9 (40.9%)
PCR (positive)	8 (36.4%)
PCR (negative)	3 (13.6%)
PCR (N/A)	11 (50%)
Pathology (positive)	2 (9.1%)
Pathology (negative)	4 (18.2%)
Pathology (N/A)	16 (72.7%)
Fungal culture (positive)	10 (45.5%)
Fungal culture (negative)	2 (9.1%)
Fungal culture (N/A)	10 (45.5%)
Site of positive culture (sputum)	2 (9.1%)
Site of positive culture (BAL)	6 (27.3%)
Site of positive culture (sinus biopsy)	4 (18.2%)
Site of positive culture (pulmonary biopsy)	1 (4.5%)
Site of positive culture (peritonitis)	1 (4.5%)
CT scan findings (nodules)	11 (50%)
CT scan findings (ground glass opacity)	2 (9.1%)
CT scan findings (halo sign)	10 (45.5%)
CT scan findings (consolidation)	5 (22.7%)
CT scan findings (cavity)	3 (13.6%)
CT scan findings (pleural effusion)	7 (31.8%)
Treatment response at 6 & 12 wk (cure)	10 (45.5%)
Treatment response at 6 & 12 wk (partial response)	4 (18.2%)
Treatment response at 6 & 12 wk (stable)	-
Treatment response at 6 & 12 wk (progression)	-
Treatment response at 6 & 12 wk (death)	8 (36.4%)
12- month mortality	10 (4.45%)

¹Cases information are attached.

BAL: Bronchoalveolar lavage; CT: Computed tomography; PCR: Polymerase chain reaction; N/A: Not applicable.